ANCORS

CONNECTED DEVELOPMENT

TO PRODUCTION,

BETTER QUALITY

An integrated development process connecting planning to production,

delivering superior product quality and manufacturing stability.

R&D process

StructuredDevelopment Process

A step-by-step development framework from global trend analysis to raw material validation and testing.

01

TREND ANTICIPATION

Trend Anticipation

Global research data insights

Next-generation market trend forecasting

Identifying optimal development timing for brand strategy

02

GLOBAL STANDARD DEVELOPMENT

Global Standard Formulation Design

Formulation design reflecting each country's regulatory environment

Optimization by climate and lifestyle conditions

Prescription design tailored to individual brand strategies

03

MATERIAL & INGREDIENT VALIDATION

Material & Ingredient Pre-validation

Review of global-standard ingredient data

Ingredient selection focused on efficacy and stability

Securing regulatory-compliant material options by market

04

PILOT & PRE-PRODUCTION TESTING

Pilot & Pre-production Testing

Formulation validation through pilot-scale production

Pre-confirmation of process suitability

Validation to minimize mass-production risk

Quality ControlGate System

Every product passes through 4 quality control gates — from raw materials to shipment.

GATE 1

Pre-intake Inspection

Full COA review of incoming materials / In-house physicochemical testing / Full return of below-standard materials / Supplier grade management integration

GATE 2

Post-compounding Inspection

Full check of viscosity, pH, and appearance after compounding / Immediate re-compounding if specification deviation exceeds ±5% / Automated MES recording

GATE 3

Post-filling & Packaging Inspection

Microbial limit testing, safety, and full label verification. AQL-based sampling achieves inspection reliability equivalent to 100% testing.

GATE 4

Pre-shipment Inspection

Final specification re-verification + complete LOT traceability records. Shipment halted immediately upon any anomaly. Entire process automatically recorded and retained in MES.

15 YEARSOF BUILDING

From 2009 to the present — the trajectory of R&D at ANCORS.

2024–20232022–20202018–20152012–2009

2024–2023

2024

228 IP rights, 80 researchers, 114 patents

IP

2023

Korea Beauty Industry Award — Innovation Manufacturer, KRW 117B revenue achieved

Award

2022–2020

2022

Regulatory & licensing lab established; FDA, EU & NMPA frameworks built

Global

2020

70+ patents surpassed; Smart Factory R&D integration

IP

2018–2015

2018

ISO 22716 certified; concentrated sun care patent acquisition

Cert.

2015

30+ researchers reached; 20 cumulative patents

Growth

2012–2009

2012

First hydrogel mask formulation patent acquired

IP

2009

Corporation founded & R&D center established

Founded

YOUR BEAUTY,OUR MISSION.

© 2026 ANCORS Co., Ltd.. All rights reserved.

—
—